Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2000 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year
Filters applied: . Clear all
Page 1
Structural aspects of agonism and antagonism in the oestrogen receptor.
Pike AC, Brzozowski AM, Walton J, Hubbard RE, Bonn T, Gustafsson JA, Carlquist M. Pike AC, et al. Among authors: brzozowski am. Biochem Soc Trans. 2000;28(4):396-400. Biochem Soc Trans. 2000. PMID: 10961927 Review.
We have determined the three-dimensional structures of both alpha- and beta-forms of the ligand-binding domain of the oestrogen receptor (ER) in complexes with a range of receptor agonists and antagonists. ...In addition, these studies provide a unique insigh …
We have determined the three-dimensional structures of both alpha- and beta-forms of the ligand-binding domain of the oestrogen re
Molecular basis of agonism and antagonism in the oestrogen receptor.
Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engström O, Ohman L, Greene GL, Gustafsson JA, Carlquist M. Brzozowski AM, et al. Nature. 1997 Oct 16;389(6652):753-8. doi: 10.1038/39645. Nature. 1997. PMID: 9338790
The physiological effects of these steroids are mediated by a ligand-inducible nuclear transcription factor, the oestrogen receptor (ER). Hormone binding to the ligand-binding domain (LBD) of the ER initiates a series of molecular events culminating in the ac …
The physiological effects of these steroids are mediated by a ligand-inducible nuclear transcription factor, the oestrogen recepto